Single neuron power

Training the brain to control a single neuron 's activation could restore motion in paralyzed limbs, according to a study to be published tomorrow in linkurl:__Nature.__;http://www.nature.com/news/2008/081015/full/news.2008.1170.html The study represents a novel approach for developing neuroprosthetics. "This paper demonstrates that simple methods can be very useful," said Leigh Hochberg, a clinician and researcher at Brown University and other institutions, who was not involved with the study.

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Training the brain to control a single neuron 's activation could restore motion in paralyzed limbs, according to a study to be published tomorrow in linkurl:__Nature.__;http://www.nature.com/news/2008/081015/full/news.2008.1170.html The study represents a novel approach for developing neuroprosthetics. "This paper demonstrates that simple methods can be very useful," said Leigh Hochberg, a clinician and researcher at Brown University and other institutions, who was not involved with the study. Previous attempts at designing neuroprosthetics have focused on decoding the activity of a group of neurons associated with movement. Chet Moritz and colleagues from the University of Washington, however, went for individual cells --- by teaching monkeys to control the firing of a single neuron in their motor cortex, using biofeedback in order to power electrodes implanted in a paralyzed hand. The work fuses two different approaches in neuroprosthetic design -- direct muscle stimulation and brain-machine interfaces. Robert Kirsch and Hunter Peckham and others at the Cleveland Functional Electrical Stimulation Center at Case Western Reserve University have been working on linkurl:implanting electrodes;http://fescenter.org/index.php into muscles surrounding paralyzed limbs, allowing humans to perform tasks like standing, walking, or reaching out and grasping a cup. Meanwhile, in the BrainGate project, Hochberg, John Donoghue and colleagues implanted electrodes directly into the brain of a linkurl:paralyzed man,;http://www.cyberkineticsinc.com/content/clinicaltrials/braingate_trials.jsp allowing him to control a computer cursor and a robotic arm. "We use the simplest possible conversion from nerve activity to muscle activity," Moritz told The Scientist. They avoided using complex algorithm to interpret averaged neuronal activity, because averaged information "could confuse the patient." The researchers implanted sensors into the brains of two monkeys to record the activity of individual neurons within the motor cortex. These recordings were routed to computers outside of the monkey's body, which translated the brain signals into electrical impulses that activated electrodes implanted into muscles in the monkey's wrist. The researchers then temporarily paralyzed the animals' wrists with anaesthetic -- the only way the monkeys could move the muscles that activated their wrists was to learn to control those electrical pulses. The reward for successfully controlling the brain-to-wrist muscle connection: applesauce. It took the monkeys between 10 to 30 minutes to gain control of a single neuron while doing the task; not only were they able to control their muscle contraction, but the monkeys were also able to control the force of that contraction by regulating neuron firing rates. Surprisingly, the biofeedback training also worked for motor cortex neurons that didn't normally control wrist movement, said Moritz. "We found that the motor neuron system is remarkable in learning to use this system." Moritz estimated that it will take about five to ten years before the technology is ready for human trials. First, the sensor will have to be made fully implantable (in the monkeys, part of the electrode stuck through the skin to allow researcher to manipulate it). Also, due to the brain's natural movement and the build-up of scar tissue, implanted sensors usually lose connection to their target neurons within a few weeks, at best. Researchers are working on a new generation of sensors that would keep the connection longer or move to a new neuron when a connection is lost. Another major hurdle, said Moritz, will be to scale up the system to be able to control more muscles, thus increasing movement complexity. That means users would have to practice "each day for several hours," in order to make some of those brain-muscle associations automatic. "You can only pay attention to about seven things at once," he said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies